Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05133102 · ClinicalTrials.gov registry record
Longitudinal Oral Microbiome Sampling for BE
A clinical trial of Barrett Esophagus, sponsored by Columbia University.
- Recruiting
- Registry status
- 275
- Enrollment target
- 2
- Study locations
NCT05133102 is a study of Barrett Esophagus that is actively recruiting participants, run by Columbia University. The registered enrollment target is 275 participants, below the 3,557-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05133102, a study of Barrett Esophagus, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 275 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.
Conditions Studied
Interventions
- OTHER Sample collection
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2021-03-19 |
| Est. Completion | 2026-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05133102
The ClinicalTrials.gov registry entry for NCT05133102 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,557-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (92% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Sample collection is the first listed.
NCT05133102 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, New York.
Frequently Asked Questions
What is clinical trial NCT05133102 about?
NCT05133102 is a clinical study titled "Longitudinal Oral Microbiome Sampling for BE". This is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.
What is the current status of trial NCT05133102?
This trial is currently recruiting. The enrollment target is 275 participants. The study started on 2021-03-19. Estimated completion is 2026-08.
What conditions does trial NCT05133102 study?
This clinical trial studies the following conditions: Barrett Esophagus.
What interventions are being tested in trial NCT05133102?
The interventions under investigation include: Sample collection (OTHER).
Who is sponsoring clinical trial NCT05133102?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05133102 being conducted?
This trial has 2 study locations across Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
-
Obeticholic Acid for Prevention in Barrett's Esophagus
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.